Pharmaceutical Merger Puzzles Analysts

Pharmaceutical Merger Puzzles Analysts


Save Story
Leer en espaƱol

Estimated read time: Less than a minute

This archived news story is available only for your personal, non-commercial use. Information in the story may be outdated or superseded by additional information. Reading or replaying the story in its archived form does not constitute a republication of the story.

(Salt Lake City-AP) -- Salt Lake City's N-P-S Pharmaceuticals -- to the surprise of some analysts -- announced it would acquire Enzon Pharmaceuticals of New Jersey in a deal valued at nearly one (B)billion dollars.

After the announcement, N-P-S stock tumbled by 25 percent. Enzon lost eight percent yesterday.

N-P-S officers said they were unruffled by the market's reaction, convinced time will convince investors that the newly merged company will be profitable.

The newly combined company, yet to be named, will have headquarters in New Jersey. There was no word on any work force adjustments, though the companies committed to maintaining major research, development and manufacturing facilities in Salt Lake City, as well as Toronto and Indianapolis.

(Copyright 2003 by The Associated Press. All Rights Reserved.)

Most recent Utah stories

Related topics

Utah

STAY IN THE KNOW

Get informative articles and interesting stories delivered to your inbox weekly. Subscribe to the KSL.com Trending 5.
By subscribing, you acknowledge and agree to KSL.com's Terms of Use and Privacy Policy.

KSL Weather Forecast